| Filed | Form | Issuer | Stake | Shares | |
|---|---|---|---|---|---|
| 2026-07-10 | SCHEDULE 13D/A | BridgeBio Pharma, Inc. BBIO | 5.00% | 9,792,219 | view → |
| 2026-06-12 | SCHEDULE 13D | STANDARD BIOTOOLS INC. LAB | 15.00% | 58,651,170 | view → |
| 2026-05-18 | SCHEDULE 13G | Artiva Biotherapeutics, Inc. ARTV | — | — | view → |
| 2026-04-02 | SCHEDULE 13D/A | BridgeBio Pharma, Inc. BBIO | 6.10% | 11,842,434 | view → |
| 2025-07-01 | SCHEDULE | BridgeBio Pharma, Inc. BBIO | 9.80% | 18,602,920 | view → |
| 2025-01-31 | SCHEDULE | BridgeBio Pharma, Inc. BBIO | 11.70% | 22,055,375 | view → |
| 2023-11-07 | SC | Cazoo Group Ltd | — | — | view → |
| 2023-09-22 | SC | Cazoo Group Ltd | — | — | view → |
| 2023-07-20 | SC | BridgeBio Pharma, Inc. BBIO | — | — | view → |
| 2023-04-27 | SC | Cazoo Group Ltd | — | — | view → |
| 2023-02-27 | SC | Cazoo Group Ltd | — | — | view → |
| 2022-03-04 | SC | Ginkgo Bioworks Holdings, Inc. DNABW | — | — | view → |
| 2021-10-01 | SC | Ginkgo Bioworks Holdings, Inc. DNABW | — | — | view → |
| 2019-07-12 | SC | Myovant Sciences Ltd. | — | — | view → |
| 2019-07-12 | SC | Arbutus Biopharma Corp ABUS | — | — | view → |
| 2019-07-12 | SC | Urovant Sciences Ltd. | — | — | view → |
| 2019-07-12 | SC | Axovant Gene Therapies Ltd. | — | — | view → |
| 2019-03-19 | SC | Axovant Sciences Ltd. | — | — | view → |
| 2019-01-03 | SC | Arbutus Biopharma Corp ABUS | — | — | view → |
| 2019-01-03 | SC | Urovant Sciences Ltd. | — | — | view → |
Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.
See pricing →